Literature DB >> 6028273

Cerebral vascular disease in Hiroshima, Japan.

K G Johnson, K Yano, H Kato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6028273     DOI: 10.1016/0021-9681(67)90085-9

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


× No keyword cloud information.
  8 in total

1.  Cerebro-vascular diseases in Negroes.

Authors:  S J Oh
Journal:  J Natl Med Assoc       Date:  1971-03       Impact factor: 1.798

2.  Sex differences in the incidence of cerebrovascular disease.

Authors:  S Haberman; R Capildeo; F C Rose
Journal:  J Epidemiol Community Health       Date:  1981-03       Impact factor: 3.710

3.  Smoking and subarachnoid haemorrhage.

Authors:  K M Sheikh
Journal:  J R Soc Med       Date:  1982-11       Impact factor: 5.344

4.  Cerebrovascular disease in north-west India: a study of necropsy material.

Authors:  A K Banerjee; M Varma; R K Vasista; J S Chopra
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

5.  Epidemiologic features of cerebrovascular disease in Manitoba: incidence by age, sex and residence, with etiologic implications.

Authors:  H A Abu-Zeid; N W Choi; N A Nelson
Journal:  Can Med Assoc J       Date:  1975-09-06       Impact factor: 8.262

6.  Meta-analysis of relation between cigarette smoking and stroke.

Authors:  R Shinton; G Beevers
Journal:  BMJ       Date:  1989-03-25

7.  Understanding the Pathophysiology and Challenges of Development of Medical Countermeasures for Radiation-Induced Vascular/Endothelial Cell Injuries: Report of a NIAID Workshop, August 20, 2015.

Authors:  Merriline M Satyamitra; Andrea L DiCarlo; Lanyn Taliaferro
Journal:  Radiat Res       Date:  2016-07-07       Impact factor: 2.841

8.  Ghrelin Therapy Decreases Incidents of Intracranial Hemorrhage in Mice after Whole-Body Ionizing Irradiation Combined with Burn Trauma.

Authors:  Nikolai V Gorbunov; Juliann G Kiang
Journal:  Int J Mol Sci       Date:  2017-08-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.